Jonathan Lamb Email & Phone Number

Horley

General Counsel to the Stark Group of Companies, a full circle energy data, analytics and infrastructure business.

Providing ad hoc legal consultancy services to corporates.

Closing of a project finance transaction in the British Virgin Islands (BVI) for the construction (based on FIDIC silver book), operation and maintenance of new, and overhaul of old, water infrastructure in the BVI (ECGD –ECA, Barclays –lender to the SPC) followed by sale of BVI asset;Closing of Water Services Agreement with the Kurdistan Regional Government based on FIDIC yellow book for design, construction and operation and maintenance of +$1 billion in water and wastewater assets;Closing of a joint venture relating to a wastewater treatment plant on Stonecutters Island, Hong Kong upgraded and extended to handle wastewater treatment for over five million residents;Oversight of litigation in the Philippines, Panama & UAE; Sale of Hong Kong Subsidiary; Oversight and implementation of Bribery Act 2010 (ABC) anti-bribery and corruption policies and procedures across the Biwater Group’s operations in Europe, Africa, Asia and the Americas; andSetting up of GDPR and data privacy policies and systems.

General Counsel, Compliance Officer & Company Secretary of Cascal N.V, an international water company, listed on the NYSE. Responsibilities have included filings with the SEC in the U.S and the formation and implementation of corporate governance and SOX compliance policies.Member of Cascal’s Management Board reporting into Cascal’s CEO and its Board. Experience includes: • Day-to-day legal support and advice to Cascal and its subsidiaries across the world with an emphasis on corporate transactions; • Refinancing of Cascal’s main corporate banking facility, in June 2008 & July 2009;• Advising on a dispute with the Government of Panama and an international arbitration taking place in Panama;• As Company Secretary of the holding company wide experience including corporate governance, the production of board minutes and related papers and filings, reporting to the SEC and NYSE in the US in Cascal’s first year of being a public company, overseeing Group insurances, litigation and risk management strategy and overseeing SOX and NYSE compliance;• The acquisition of two Chilean water companies for approximately $22 million; and• Oversight of bid defence strategy spanning three jurisdictions ( USA ( NYSE), Netherlands and UK) in hostile take over.

Head of Legal for a family office overseeing, an international group of companies comprising the personal and corporate assets of an ultra high net worth individual with an asset value in the region of $7 billion. Experience includes:• “asset swap” of 50% of the shares of a Russian Bank for 50% of a Russian Fertilizer business coupled with a group restructuring . Asset values in excess of USD$3 billion;• Restructuring of Antilles’ group to incorporate a Bermudian private trust company holding structure and the re-domiciliation of the group’s holding company from Madeira (Portugal) to Bermuda;• Acquisition of investment management companies in Guernsey and the UK;• Setting up of hedge fund in Guernsey;• Purchase of Boeing Business Jet ; • hiring and firing of staff, in various jurisdictions, leasing of premises, contractor and consultancy arrangements and ad hoc commercial contracts, disputes and issues as they arise; and• The oversight and execution of the shut down of Antilles UK operations.

Biotechnology company listed on NASDAQ. Member of Amarin’s Executive Committee reporting into Amarin’s CEO and its Board. Experience included: • All day-to-day legal support and advice to Amarin and its subsidiaries across the world with an emphasis on corporate transactions; • Registered direct offering in May 2005 pursuant to a shelf filing with the SEC;• Three private placements of shares;• The sale of Swedish drug development subsidiary; • The rescheduling of Amarin’s debt payments due to its main creditor; • The sale of its U.S.-based subsidiary and a majority of its U.S. products to Valeant Pharmaceuticals International in a cash transaction;• The acquisition of Laxdale Limited in an all paper transaction for 3.5 million ADRs together with deferred consideration in July 2004; and Corporate governance, the production of board minutes and related papers and filings, reporting to the SEC and NASDAQ in the US, setting up and processing of the Group’s share option schemes, overseeing Group insurances, litigation and risk management strategy, and overseeing property issues.

Senior Legal Advisor engaged in the day-to-day activities of a global company listed on the London Stock Exchange, NASDAQ and in Toronto.Experience included:• working with UK subsidiary with regard to supply contracts with UK distributors, NHS and or NHS Trusts.• Involvement in the Shire/BioChem merger (value c. US $4 billion),. • The main day to day legal contact at Shire in respect of its $350 million convertible bond issue in 2001 • ‘Upstream’ and ‘downstream’ patent and know how licences for Shire and in particular its US drug delivery subsidiary Shire Laboratories Inc;• Product acquisition and divestment agreements; and• R&D and contract research agreements.

Partner (1998), Associate (1996) and Assistant Solicitor in corporate department.

Assistant Solicitor based in the Company/Commercial Department

Law Society Finals

Llb, Law

Activities and Societies: Rugby League (inc. President 1989), 2:1

Education record